This pharma stock has zoomed 567% in 40 trading days post re-listing

 This pharma stock has zoomed 567% in 40 trading days post re-listing

According to latest shareholding pattern data, the company’s promoter held 98.04 per cent stake

Topics
Orchid Pharma | Buzzing stocks | Markets

SI Reporter | Mumbai

stocks, india inc, markets, investment, shares, dividends, brokers, shares, company, firms, BSE, exchange, earnings, results, profit, loss, dividend payout, tax

Shares of Orchid Pharma were locked in upper circuit for the 40th straight trading day, up 5 per cent at Rs 120.13 on the BSE on Wednesday. The stock has zoomed 567 per cent from the level of Rs 18, since its relisting on November 3, 2020.

Till 12: 35 pm, a combined only 83 equity shares had changed hands and there were pending buy orders for 135,000 shares on the BSE and NSE, the exchange data shows. In comparison, the S&P BSE Sensex was down 0.28 per cent at 47,478 points.

Currently, Orchid Pharma is trading under T group on the BSE. In the T2T segment, each trade has to result in delivery and no intra-day netting of positions is allowed.

According to latest shareholding pattern data, the promoter Dhanuka L

Read More

Redak staff

Leave a Reply

Your email address will not be published.